Treatment of dementia.
作者信息
Overshott R, Burns A
机构信息
Department of Old Age Psychiatry, Wythenshawe Hospital, Manchester M23 9LT, UK.
出版信息
J Neurol Neurosurg Psychiatry. 2005 Dec;76 Suppl 5(Suppl 5):v53-9. doi: 10.1136/jnnp.2005.082537.
Abstract
摘要
相似文献
1
Treatment of dementia.
J Neurol Neurosurg Psychiatry. 2005 Dec;76 Suppl 5(Suppl 5):v53-9. doi: 10.1136/jnnp.2005.082537.
2
Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
Neurology. 2007 Apr 24;68(17):1356-63. doi: 10.1212/01.wnl.0000260060.60870.89.
3
Dementia update. Pharmacologic management of agitation and psychosis in older demented patients.
Geriatrics. 2003 Oct;58(10):48-50, 52-3.
4
Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action.
Int Psychogeriatr. 2014 Jun;26(6):879-83. doi: 10.1017/S1041610214000477. Epub 2014 Apr 4.
5
[Antipsychotic drug therapy for patients with behavioral and psychological symptoms of dementia(BPSD)].
Seishin Shinkeigaku Zasshi. 2007;109(7):657-63.
6
Antidepressants for agitation and psychosis in patients with dementia.
Am Fam Physician. 2012 Jan 1;85(1):20-2.
7
Treatment strategies for agitation and psychosis in dementia.
J Clin Psychiatry. 1996;57 Suppl 14:21-9.
8
Agitation and psychosis in dementia.
Am J Geriatr Psychiatry. 2007 Nov;15(11):913-7. doi: 10.1097/JGP.0b013e3181584268.
9
Duration of risperidone treatment for BPSD.
Int J Geriatr Psychiatry. 2006 Jul;21(7):699-701. doi: 10.1002/gps.1559.
10
The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.
Am J Psychiatry. 2016 May 1;173(5):543-6. doi: 10.1176/appi.ajp.2015.173501.
引用本文的文献
1
Clinical Practice Guidelines for Dementia: Recommendations for Cholinesterase Inhibitors and Memantine.
Dement Neurocogn Disord. 2025 Jan;24(1):1-23. doi: 10.12779/dnd.2025.24.1.1. Epub 2025 Jan 20.
2
Omega-3 Fatty Acids for Depression in the Elderly and Patients with Dementia: A Systematic Review and Meta-Analysis.
Healthcare (Basel). 2024 Feb 23;12(5):536. doi: 10.3390/healthcare12050536.
3
Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms.
Genes (Basel). 2023 Nov 6;14(11):2048. doi: 10.3390/genes14112048.
4
A Web-Based Model to Predict a Neurological Disorder Using ANN.
Healthcare (Basel). 2022 Aug 5;10(8):1474. doi: 10.3390/healthcare10081474.
5
Morphological classification and changes in dementia (Review).
Exp Ther Med. 2022 Jan;23(1):33. doi: 10.3892/etm.2021.10955. Epub 2021 Nov 9.
6
Computerized attention training for visually impaired older adults with dementia: a case study.
Dement Neuropsychol. 2020 Dec;14(4):430-433. doi: 10.1590/1980-57642020dn14-040015.
7
Role of Fluid Biomarkers and PET Imaging in Early Diagnosis and its Clinical Implication in the Management of Alzheimer's Disease.
J Alzheimers Dis Rep. 2020 Feb 12;4(1):21-37. doi: 10.3233/ADR-190143.
8
Effects of Physical Activity in Nursing Home Residents with Dementia: A Randomized Controlled Trial.
Dement Geriatr Cogn Disord. 2018;46(1-2):60-80. doi: 10.1159/000491818. Epub 2018 Aug 24.
9
Novel Effects of Extract on Patients with Neurocognitive Disorder and Depression: A Clinical Trial Study.
Int J Prev Med. 2018 Jun 29;9:57. doi: 10.4103/ijpvm.IJPVM_199_17. eCollection 2018.
10
Cognitive function in a general population of men and women: a cross sectional study in the European Investigation of Cancer-Norfolk cohort (EPIC-Norfolk).
BMC Geriatr. 2014 Dec 19;14:142. doi: 10.1186/1471-2318-14-142.
本文引用的文献
1
Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials.
BMJ. 2005 Aug 6;331(7512):321-7. doi: 10.1136/bmj.331.7512.321.
2
Treatments for Alzheimer disease.
South Med J. 2005 Jun;98(6):628-35. doi: 10.1097/01.SMJ.0000166671.86815.C1.
3
Drugs used to relieve behavioral symptoms in people with dementia or an unacceptable chemical cosh? Argument.
Int Psychogeriatr. 2005 Mar;17(1):4-12; discussion 22-9. doi: 10.1017/s1041610205221026.
4
Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
Clin Neurol Neurosurg. 2005 Oct;107(6):497-508. doi: 10.1016/j.clineuro.2005.03.013.
5
Nonpharmacological and pharmacological interventions for symptoms in Alzheimer's disease.
Expert Rev Neurother. 2004 Sep;4(5):809-21. doi: 10.1586/14737175.4.5.809.
6
Rivastigmine for dementia associated with Parkinson's disease.
N Engl J Med. 2004 Dec 9;351(24):2509-18. doi: 10.1056/NEJMoa041470.
7
Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration.
Dement Geriatr Cogn Disord. 2004;18(2):217-26. doi: 10.1159/000079388. Epub 2004 Jun 28.
8
Evidence-based pharmacotherapy of Alzheimer's disease.
Int J Neuropsychopharmacol. 2004 Sep;7(3):351-69. doi: 10.1017/S1461145704004444. Epub 2004 Jul 1.
9
Atypical antipsychotics and risk of cerebrovascular accidents.
Am J Psychiatry. 2004 Jun;161(6):1113-5. doi: 10.1176/appi.ajp.161.6.1113.
10
Emerging therapies for vascular dementia and vascular cognitive impairment.
Stroke. 2004 Apr;35(4):1010-7. doi: 10.1161/01.STR.0000120731.88236.33. Epub 2004 Mar 4.
Zotero 插件